Surgery for brain tumors that may come back
Part of Brain & nervous system, Cancer clinical trials.
This study tests whether removing a brain tumor early, before it shows signs of growing back, can help prevent a recurrence. If you have had treatment before and there is still some tumor left, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a brain tumor confirmed by a biopsy or imaging.
- You have already had chemotherapy or radiation for the tumor.
- You still have some tumor visible on an MRI or CT scan that has not been removed.
- You are willing to have surgery and sign a consent form.
- You are not eligible for another clinical trial that might be a better fit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SRN-101 that is given directly into the brain tumor before surgery to remove it. The goal is to see if it is safe and could help people with a brain tumor that has come back after standard treatment.
This study tests FT536, a new cell-based treatment, for people with a specific type of brain cancer (WHO Grade 4 astrocytoma) that has come back after standard treatment. The trial combines the new therapy with surgery to see if it can help stop the cancer from growing further.
This trial studies whether operating on a brain tumor that has returned can help people with recurrent glioblastoma. It focuses on people whose scans suggest surgery is safe for important speech and movement brain areas.
This trial compares surgery to the best non-surgical treatment for people whose glioblastoma has come back. The goal is to see which approach helps people live longer with a better quality of life.
This trial collects tumor samples to study what causes glioblastoma to return. It may help scientists find better treatments.
This study follows people with lower-grade (WHO grade 2 or less) brain tumors using repeat MRI scans over time. It helps doctors understand how these tumors change and which patients may safely delay treatment at first.
Hear when a new Brain Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.